January 1, 2021Liver Cancer91 citationsOpen Access
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Key Points
Key points are not available for this paper at this time.
Abstract
achievement of marked tumor shrinkage," which differs from the treatment concept for other types of advanced cancer or advanced HCC. Upfront Systemic Therapy with Subsequent Locoregional Therapy/Resection in Intermediate-Stage HCC